Profil
Dennis J.
Church is currently the Director of Research & Alliance at Xigen SA. Prior to this, he worked as a Principal at Glaxo-Welcome's Research Institute.
Postes actifs de Dennis J. Church
| Sociétés | Poste | Début |
|---|---|---|
Xigen SA
 Xigen SA Pharmaceuticals: MajorHealth Technology Xigen SA develops intracellular peptide therapeutics for the treatment of stroke, myocardial infarction and cancer. It focuses on the acute or short-term treatment of major debilitating pathologies that underly unmet medical needs plaguing humanity. The company was founded in 2002 and is headquartered in Epalinges, Switzerland. | Corporate Officer/Principal | 17/11/2009 |
Anciens postes connus de Dennis J. Church
| Sociétés | Poste | Fin |
|---|---|---|
| Glaxo-Welcomes' Research Institute | Corporate Officer/Principal | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 2 |
|---|---|
Xigen SA
Xigen SA Pharmaceuticals: MajorHealth Technology Xigen SA develops intracellular peptide therapeutics for the treatment of stroke, myocardial infarction and cancer. It focuses on the acute or short-term treatment of major debilitating pathologies that underly unmet medical needs plaguing humanity. The company was founded in 2002 and is headquartered in Epalinges, Switzerland. | Health Technology |
| Glaxo-Welcomes' Research Institute |
